PGD2 Deficiency Exacerbates Food Antigen-Induced Mast Cell Hyperplasia

Total Page:16

File Type:pdf, Size:1020Kb

PGD2 Deficiency Exacerbates Food Antigen-Induced Mast Cell Hyperplasia ARTICLE Received 14 Apr 2015 | Accepted 15 May 2015 | Published 10 Jul 2015 DOI: 10.1038/ncomms8514 PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia Tatsuro Nakamura1, Shingo Maeda1, Kazuhide Horiguchi2, Toko Maehara1, Kosuke Aritake3, Byung-il Choi4, Yoichiro Iwakura5, Yoshihiro Urade3 & Takahisa Murata1 Prostaglandin D2 (PGD2) is a major prostanoid secreted mainly by mast cells. Although PGD2 has been identified as a modulator of allergic inflammation, its precise role remains unclear. Here we investigate the role of PGD2 in food allergy. Oral administration of ovalbumin induces allergic responses in sensitized wild-type (WT) mice. Systemic gene deficiency of haematopoietic PGD synthase (H-PGDS À / À ) exacerbates all of the manifestations accompanying severe mast cell hyperplasia in the intestine. Morphological studies show that c-kit/FceRI-positive WT mast cells strongly express H-PGDS. Transplantation of H-PGDS À / À mast cells also aggravates ovalbumin-induced mast cell hyperplasia and allergic symptoms in mast cell null mice. H-PGDS deficiency accelerates the production of SDF-1a and the activity of MMP-9 in the antigen-stimulated intestine. SDF-1a receptor blockade or MMP-9 inhibition relieves the exacerbated mast cell hyperplasia and manifestations observed in H-PGDS À / À . Thus, PGD2 deficiency results in food antigen-induced mast cell hyperplasia. 1 Department of Animal Radiology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan. 2 Department of Morphological and Physiological Sciences, University of Fukui, Fukui 910-1193, Japan. 3 International Institute for Integrative Sleep Medicine, University of Tsukuba, Ibaraki 305-8575, Japan. 4 Department of Anatomy, College of Medicine, Korea University, Seoul 136-701, Korea. 5 Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-0022, Japan. Correspondence and requests for materials should be addressed to T.M. (email: [email protected]). NATURE COMMUNICATIONS | 6:7514 | DOI: 10.1038/ncomms8514 | www.nature.com/naturecommunications 1 & 2015 Macmillan Publishers Limited. All rights reserved. ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8514 ood allergy is defined as an abnormal immune response to chemoattractant receptor-homologous molecule expressed on food proteins. The number of patients with food allergies Th2 cells (CRTH2). The dehydration product of PGD2, 15-deoxy- Fhas doubled within the last several decades. Currently, delta PGJ2 (15d-PGJ2), also has bioactivity via peroxisome 8 2–10% of the human population suffers from hypersensitivity to proliferator-activated receptors . Although PGD2 has emerged certain food proteins1. Symptoms affecting the skin, lung as a mast cell-derived allergic mediator, there is uncertainty and gastrointestinal (GI) tract include eczema, laboured regarding its contribution to allergic inflammation. Several breathing and diarrhoea. In serious cases, hypersensitivity to studies have reported a pro-inflammatory role associated with food antigens may lead to systemic anaphylaxis reactions, thus PGD2 signalling. Inhalation of PGD2 induced nasal blockage via 9 threatening the life of the patient. Since few effective treatments the DP receptor in atopic rhinitis patients . In addition, PGD2 are available for these reactions, the remaining option for patients enhanced airway inflammation by accumulation of inflammatory is to avoid the causative antigens (that is, specific foods). cells via the DP receptor on epithelial cells10,11. Conversely, other Therefore, the development of new clinical applications for studies have suggested anti-inflammatory roles for PGD2.In food allergies is urgently needed. mouse asthma model, DP agonism reduced eosinophilia and Mast cells are major players in allergic diseases. Following the airway hyperresponsiveness12, whereas CRTH2 agonism onset of inflammation, several chemoattractants are produced restricted the recruitment of eosinophils by limiting the that stimulate the release of mast cell progenitors (MCps) from production of interleukin (IL)-5 (ref. 13). Thus, the role of 2 bone marrow (BM) into the circulation . Circulating MCps PGD2 signalling in allergic response remains poorly understood. migrate and mature peripherally in connective or mucosal tissues. In this study, we investigated the role of PGD2 in food allergy Stem cell factor (SCF) plays a central role in chemoattraction and using genetically modified mice. We found that lack of PGD2 the proliferation and maturation of MCps3. Stromal-derived results in food antigen-induced mast cell hyperplasia. factor (SDF)-1a and tumour necrosis factor (TNF)-1a are also known to induce migration of MCps into peripheral tissues4. In the sensitization phase of allergy, the uptake of a food Results antigen activates T- or B-lymphocytes to produce immunoglo- H-PGDS deficiency exacerbates food allergy. Naive bulin E (IgE), which binds to mast cells through its high affinity H-PGDS À / À mice with a C57BL/6-background did not receptor FceRI. Upon re-uptake of antigens, IgEs are crosslinked, present any congenital GI tract abnormalities, such as changes which in turn degranulates the mast cells to release a in morphology (Supplementary Fig. 1a,b), epithelial permeability large number of inflammatory mediators, including histamine, (Supplementary Fig. 1c), mRNA expression of inflammatory platelet-activator factor (PAF), cysteinyl leukotrienes (cys-LTs) cytokines (Supplementary Fig. 1d) or tissue serotonin content, 14 and prostaglandin D2 (PGD2). The secreted histamine rapidly which causes oral antigen-induced diarrhoea (Supplementary and strongly increases capillary permeability, whereas PAF Fig. 1e). In addition, both lines of mice showed comparative mainly induces platelet aggregation and degranulation5,6. hypothermia in IgE/mast cell-mediated passive systemic Mast cells strongly express haematopoietic PGD synthase anaphylaxis (Supplementary Fig. 1f). (H-PGDS) and produce a large amount of the arachidonic acid Diarrhoea is a representative symptom in murine models of 15 metabolite PGD2 (ref. 7). PGD2 exerts its biological actions food allergy . We assessed the stool consistency (Fig. 1a) and though two distinct receptors, D prostanoid (DP) and the scored other systemic responses including scratching, immobility a b c ‡ ) H-PGDS –/– –1 1.6 H-PGDS –/– ‡ ‡ 2.5 ‡ WT ‡ 1.6 –/– ‡ ‡ g ml H-PGDS 1.2 2.0 µ ‡ 1.2 ‡ 1.5 0.8 ‡ 0.8 1.0 * Faeces score 0.4 WT 0.4 † Systemic score 0.5 WT 0 0 0 OVA-specific IgE ( 0246810 0246810 Saline ×10 OVA OVA challenge (times) OVA challenge (times) d e f 80 Balb/c H-PGDS –/– ×3 OVA ×5 OVA –/– 3.0 Balb/c H-PGDS ‡ 0.0 60 ‡ 2.0 40 –0.4 1.0 Diarrhoea (%) 20 Balb/c WT Systemic score Balb/c WT –0.8 0 0 WT ‡ –1.2 H-PGDS –/– 0 246810 0246810 Body temperature drop (°C) OVA challenge (times) OVA challenge (times) Figure 1 | H-PGDS deficiency exacerbates OVA-induced allergic reactions. Faeces score (a) and systemic score (b) were monitored in C57BL/6- background mice (n ¼ 8–12). (c) Serum OVA-specific IgE levels in mice following the tenth challenge with either saline or OVA (n ¼ 8–12). The horizontal lines indicate the means. Diarrhoea occurrence (d), systemic score (e) and hypothermia (f) were monitored in Balb/c-background mice (n ¼ 11). Diarrhoea w occurrence is represented as the percentage over the number of OVA challenges. *, , zPo0.05 compared with saline-challenged WT, saline-challenged H-PGDS À / À or OVA-challenged WT, respectively. Data are presented as mean±s.e.m. of 2–3 independent experiments. Mann–Whitney U-test was performed for comparisons in a, b and e, and Tukey’s test for comparison in c and f. 2 NATURE COMMUNICATIONS | 6:7514 | DOI: 10.1038/ncomms8514 | www.nature.com/naturecommunications & 2015 Macmillan Publishers Limited. All rights reserved. NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8514 ARTICLE and swelling (bristled fur, oedema around the nose and eyes or regardless of the mouse strain. C57BL/6 mouse lines were utilized laboured breathing; Fig. 1b). In wild-type (WT) mice, both for the subsequent experiments. scores increased after the seventh or eighth oral challenge of 50 mg ovalbumin (OVA), whereas more severe symptoms with earlier onset developed in H-PGDS À / À mice. We next H-PGDS deficiency exacerbates mast cell infiltration. Mast cells investigated whether H-PGDS deficiency affected serum IgE are located at the sites exposed to external environment such as levels. Although OVA challenges significantly increased serum GI tract and skin. We counted the infiltrated mast cells visualized OVA-specific IgE levels in both WT and H-PGDS À / À mice, by chloroacetate esterase (CAE) staining in small and large there was no significant difference between the lines after ten intestine, and also in lung and ear. The number of mast cells in times OVA challenges (Fig. 1c). those tissue was no difference between both lines of mice before Allergic responses are known to vary among mouse strains15. OVA stimulation (Supplementary Fig. 3a). OVA challenge Balb/c WT mice exhibited diarrhoea even in response to 1 mg stimulated mast cell infiltration into the intestinal tract as well as OVA (Supplementary Fig. 2a). At this lower dosage of OVA, in the other sites in WT (Fig. 2a). H-PGDS deficiency was Balb/c H-PGDS À / À showed earlier and more severe observed to accelerate mast cell infiltrations, resulting in mast cell manifestations including diarrhoea (Fig. 1d), systemic reactions hyperplasia in almost all of the
Recommended publications
  • Prostaglandin D2 Synthase: Apoptotic Factor in Alzheimer Plasma, Inducer of Reactive Oxygen Species, Inflammatory Cytokines and Dialysis Dementia
    www.nephropathol.com DOI:10.12860/JNP.2013.28 J Nephropathology. 2013; 2(3): 166-180 Journal of Nephropathology Prostaglandin D2 synthase: Apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia John K. Maesaka1,*, Bali Sodam1, Thomas Palaia1, Louis Ragolia1,Vecihi Batuman2, Nobuyuki Miyawaki 1, Shubha Shastry1, Steven Youmans3, Marwan El-Sabban4 1Department of Medicine, Winthrop-University Hospital, Mineola, N.Y., SUNY Medical School at Stony Brook, N.Y. USA. 2Department of Medicine, Tulane University School of Medicine. USA. 3Department of Biomedical Sciences, New York Institute of Technology, Westbury, N.Y. USA. 4Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut, Lebanon. ARTICLE INFO ABSTRACT Article type: Background: Apoptosis, reactive oxygen species (ROS) and inflammatory cytokines Original Article have all been implicated in the development of Alzheimer’s disease (AD). Article history: Objectives: The present study identifies the apoptotic factor that was responsible Received: 7 February 2013 for the fourfold increase in apoptotic rates that we previously noted when pig Accepted: 1 March 2013 proximal tubule, LLC-PK1, cells were exposed to AD plasma as compared to Published online: 1 July 2013 plasma from normal controls and multi-infarct dementia. Patients and Methods: The apoptotic factor was isolated from AD urine and identi- fied as lipocalin-type prostaglandin D2 synthase (L-PGDS). L-PGDS was found Keywords: Original Article Dialysis Dementia to be the major apoptotic factor in AD plasma as determined by inhibition of Alzheimer’s disease apoptosis approximating control levels by the cyclo-oxygenase (COX) 2 inhibitor, Apoptosis NS398, and the antibody to L-PGDS.
    [Show full text]
  • 615 Neuroscience-Cayman-Bertin
    Thomas G. Brock, Ph.D. Introduction to Neuroscience In our first Biology classes, we learned that lipids form the membranes around cells. For many students, interests quickly moved to the intracellular constituents ‘that really matter’, or to how cells or systems work in health and disease. If there was further thought about lipids, it might have been limited to more personal issues, like an expanding waistline. It was easy to forget about lipids in the complexities of, say, Alzheimer’s Disease, where tau protein is hyperphosphorylated by a host of kinases before forming neurofibrillary tangles and amyloid precursor protein is processed by assorted secretases, ultimately aggregating to form neurodegenerating plaques. What possible role could lipids have in all this? After all, lipids just form the membranes around cells. Fortunately, neuroscientists study complex systems. Whether working at the molecular, cellular, or organismal level, the research focus always returns to the intricately interconnected bigger picture. Perhaps surprisingly, lipids keep emerging as part of the bigger picture. At least, the smaller lipids do. Many of the smaller lipids, including the cannabinoids and eicosanoids, act as paracrine hormones, modulating cell functions in a receptor-mediated fashion. In this sense, they are rather like the peptide hormones in their diversity and actions. In the neurosystem, this means that these signaling lipids determine if synapses fire or not, when cells differentiate or die, and whether tissues remain healthy or become inflamed. Returning to the question posed above about lipids in Alzheimer’s, these mediators have roles at many levels in the course of the disease, as presented in an article on page 42 of this catalog.
    [Show full text]
  • Molecular Signatures of G-Protein-Coupled Receptors A
    REVIEW doi:10.1038/nature11896 Molecular signatures of G-protein-coupled receptors A. J. Venkatakrishnan1, Xavier Deupi2, Guillaume Lebon1,3,4,5, Christopher G. Tate1, Gebhard F. Schertler2,6 & M. Madan Babu1 G-protein-coupled receptors (GPCRs) are physiologically important membrane proteins that sense signalling molecules such as hormones and neurotransmitters, and are the targets of several prescribed drugs. Recent exciting developments are providing unprecedented insights into the structure and function of several medically important GPCRs. Here, through a systematic analysis of high-resolution GPCR structures, we uncover a conserved network of non-covalent contacts that defines the GPCR fold. Furthermore, our comparative analysis reveals characteristic features of ligand binding and conformational changes during receptor activation. A holistic understanding that integrates molecular and systems biology of GPCRs holds promise for new therapeutics and personalized medicine. ignal transduction is a fundamental biological process that is comprehensively, and in the process expand the current frontiers of required to maintain cellular homeostasis and to ensure coordi- GPCR biology. S nated cellular activity in all organisms. Membrane proteins at the In this analysis, we objectively compare known structures and reveal cell surface serve as the communication interface between the cell’s key similarities and differences among diverse GPCRs. We identify a external and internal environments. One of the largest and most diverse consensus structural scaffold of GPCRs that is constituted by a network membrane protein families is the GPCRs, which are encoded by more of non-covalent contacts between residues on the transmembrane (TM) than 800 genes in the human genome1. GPCRs function by detecting a helices.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • Estimation of Serum Prostaglandin D2 Levels and Its Expression in Tissue of Alopecia Areata
    ISSN: 2536-9474 (Print) Original article / FYMJ ISSN: 2536-9482 (Online) Fayoum University Medical Journal Soliman et al., 2019,4(1), 77-85 Estimation of serum prostaglandin D2 levels and its expression in tissue of Alopecia areata Talal A. Abd-ElRaheem1, Samar M.R. El-Tahlawy2, Olfat G. Shaker3, Mohamed H.Mohamed4 and Yasmin F.Soliman5 1. M.D, professor of Dermatology, STDs and Andrology department, Faculty of Medicine Fayoum University. 2. M.D, professor of Dermatology department, Faculty of Medicine Cairo University 3. M.D, professor of Biochemistry department, Faculty of Medicine-Cairo University 4. MD, lecturer of Dermatology, STDs and Andrology department, Faculty of Medicine Fayoum University 5. M.B.B.CH, Dermatology, STDs and Andrology department, Faculty of Medicine, Cairo University Abstract Results: There was statistically highly Back ground: Alopecia areata is a recurrent, significant difference between the two groups non-scaring type of hair loss considered to be regarding the mean value of PGD2 in tissue in an autoimmune process. Though its AA patients. It was significantly lower than in etiopathogenesis is not fully understood, many control group (p < 0.001). The mean value of therapeutic options have been used by PGD2 in serum in AA patients was dermatologists, but none are curative or significantly lower than in control group (p< preventive. Prostaglandins analogues which 0.05). are used to treat glaucoma. Increase in eye lash Conclusion: Prostaglandin D2 exhibits a number, thickness and pigmentation have been strong role in etiology of alopecia areata and reported as side effect. significantly was elevated in serum and tissue Methods: This cross sectional case control of alopecia areata patients.
    [Show full text]
  • Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Neutrophil chemoattractant receptors in health and disease: double-edged swords Mieke Metzemaekers1, Mieke Gouwy1 and Paul Proost 1 Neutrophils are frontline cells of the innate immune system. These effector leukocytes are equipped with intriguing antimicrobial machinery and consequently display high cytotoxic potential. Accurate neutrophil recruitment is essential to combat microbes and to restore homeostasis, for inflammation modulation and resolution, wound healing and tissue repair. After fulfilling the appropriate effector functions, however, dampening neutrophil activation and infiltration is crucial to prevent damage to the host. In humans, chemoattractant molecules can be categorized into four biochemical families, i.e., chemotactic lipids, formyl peptides, complement anaphylatoxins and chemokines. They are critically involved in the tight regulation of neutrophil bone marrow storage and egress and in spatial and temporal neutrophil trafficking between organs. Chemoattractants function by activating dedicated heptahelical G protein-coupled receptors (GPCRs). In addition, emerging evidence suggests an important role for atypical chemoattractant receptors (ACKRs) that do not couple to G proteins in fine-tuning neutrophil migratory and functional responses. The expression levels of chemoattractant receptors are dependent on the level of neutrophil maturation and state of activation, with a pivotal modulatory role for the (inflammatory) environment. Here, we provide an overview
    [Show full text]
  • Original Article Expression of Chemokine Receptor CXCR5 in Gastric Cancer and Its Clinical Significance
    Int J Clin Exp Pathol 2016;9(7):7202-7208 www.ijcep.com /ISSN:1936-2625/IJCEP0023559 Original Article Expression of chemokine receptor CXCR5 in gastric cancer and its clinical significance Qing Sun*, Lujun Chen*, Bin Xu, Qi Wang, Xiao Zheng, Peng Du, Dachuan Zhang, Changping Wu, Jingting Jiang Department of Tumor Biological Treatment, The Third Affiliated Hospital, Soochow University, Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, Jiangsu, China. *Equal contributors. Received January 8, 2016; Accepted March 22, 2016; Epub July 1, 2016; Published July 15, 2016 Abstract: The increased expression of chemokine receptor CXCR5 in cancers has been demonstrated. In order to characterize the expression pattern of CXCR5 in cell lines and tissues of gastric cancer and to assess clinical implications, the expression of CXCR5 mRNA in gastric cancer tissues and adjacent tissues was evaluated by real- time RT-PCR. Meanwhile, the expression of CXCR5 in cell lines of human gastric cancer was also analyzed by flow cytometry. Tissue microarray and immunohistochemistry were used to detect the protein expression of CXCR5 in human gastric cancer tissues and adjacent normal tissues. Flow cytometry results revealed the positive expression of CXCR5 in human gastric cancer cell lines such as BGC-823, SGC-7901 and HGC-27 cells. The immunohistochem- istry results showed higher expression of CXCR5 in 52.87% of gastric cancer tissues. The expression of CXCR5 in patients with tumor size less than 2.8 cm subgroup was significantly lower than that in patients with tumor size larger than 2.8 cm subgroup (P = 0.0456). There was no significant correlation between the expression of CXCR5 and other clinical parameters in gastric cancer.
    [Show full text]
  • The Impact of the Prostaglandin D2 Receptor 2 and Its Downstream Effects on the Pathophysiology of Asthma
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Ghent University Academic Bibliography Received: 1 March 2019 | Revised: 24 June 2019 | Accepted: 17 July 2019 DOI: 10.1111/all.14001 REVIEW ARTICLE The impact of the prostaglandin D2 receptor 2 and its downstream effects on the pathophysiology of asthma Christopher E. Brightling1 | Guy Brusselle2 | Pablo Altman3 1Department of Respiratory Sciences, Institute for Lung Health, University of Abstract Leicester, Leicester, UK Current research suggests that the prostaglandin D2 (PGD2) receptor 2 (DP2) is a 2 Department of Respiratory Diseases, Ghent principal regulator in the pathophysiology of asthma, because it stimulates and ampli‐ University Hospital, Ghent, Belgium 3Novartis Pharmaceuticals Corporation, East fies the inflammatory response in this condition. The DP2 receptor can be activated Hanover, NJ, USA by both allergic and nonallergic stimuli, leading to several pro‐inflammatory events, Correspondence including eosinophil activation and migration, release of the type 2 cytokines inter‐ Pablo Altman, Novartis Pharmaceuticals leukin (IL)‐4, IL‐5 and IL‐13 from T helper 2 (Th2) cells and innate lymphoid cells type Corporation, One Health Plaza East Hanover, East Hanover, NJ 07936‐1080, 2 (ILCs), and increased airway smooth muscle mass via recruitment of mesenchy‐ USA. mal progenitors to the airway smooth muscle bundle. Activation of the DP2 recep‐ Email: [email protected] tor pathway has potential downstream effects on asthma pathophysiology, including Funding information on airway epithelial cells, mucus hypersecretion, and airway remodelling, and con‐ Novartis sequently might impact asthma symptoms and exacerbations. Given the broad dis‐ tribution of DP2 receptors on immune and structural cells involved in asthma, this receptor is being explored as a novel therapeutic target.
    [Show full text]
  • New Investigational Drugs for Androgenetic Alopecia. Valente Duarte De Sousa IC 1, Tosti A
    Expert Opin Investig Drugs. 2013 May;22(5):573-89. doi: 10.1517/13543784.2013.784743. Epub 2013 Apr 4. New investigational drugs for androgenetic alopecia. Valente Duarte de Sousa IC 1, Tosti A . Author information • [email protected] Erratum in • Erratum. [Expert Opin Investig Drugs. 2015] Abstract INTRODUCTION: Androgenetic alopecia (AGA) is the most common form of hair loss, however current treatment options are limited and moderately effective. In the past few years, there has been an increased interest in deciphering the molecular mechanisms responsible for this disorder, which has opened the possibility of novel treatments that promise to not only stimulate hair growth, but also to induce formation of new hair follicles. AREAS COVERED: The future holds more effective topical treatments with less systemic side effects (such as topical 5- alfa-reductase inhibitors), prostaglandin analogs and antagonists, medications which act through the Wnt signaling pathway, stem cells for hair regeneration, platelet-rich plasma (PRP) and more effective ways of transplanting hair. A comprehensive search was made using PubMed, GoogleScholar and Clinicaltrial.gov using different combination of key words, which included AGA treatment, new treatments for AGA, Wnt pathway, prostaglandins, PRP and stem cells for hair regrowth. EXPERT OPINION: In the near future, treatments with topical 5-alfa-reductase inhibitors and prostaglandin agonists or antagonists are expected. More evidence is needed to verify the efficacy of PRP. Although hair follicle bioengineering and multiplication is a fascinating and promising field, it is still a long way from being available to clinicians. J Am Acad Dermatol. 2015 Apr;72(4):712-6.
    [Show full text]
  • CXCR6 Within T-Helper (Th) and T-Cytotoxic
    European Journal of Endocrinology (2005) 152 635–643 ISSN 0804-4643 EXPERIMENTAL STUDY CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves’ disease (GD) G Aust, M Kamprad1, P Lamesch2 and E Schmu¨cking Institute of Anatomy, 1Department of Clinical Immunology and Transfusion Medicine and 2Department of Surgery, University of Leipzig, Phillipp-Rosenthal-Str. 55, Leipzig, 04103, Germany (Correspondence should be addressed to G Aust; Email: [email protected]) Abstract Objective: In Graves’ disease (GD), stimulating anti-TSH receptor antibodies are responsible for hyperthyroidism. T-helper 2 (Th2) cells were expected to be involved in the underlying immune mech- anism, although this is still controversial. The aim of this study was to examine the expression of CXCR6, a chemokine receptor that marks functionally specialized T-cells within the Th1 and T-cyto- toxic 1 (Tc1) cell pool, to gain new insights into the running immune processes. Methods: CXCR6 expression was examined on peripheral blood lymphocytes (PBLs) and thyroid- derived lymphocytes (TLs) of GD patients in flow cytometry. CXCR6 cDNA was quantified in thyroid tissues affected by GD (n ¼ 16), Hashimoto’s thyroiditis (HT; n ¼ 2) and thyroid autonomy (TA; n ¼ 11) using real-time reverse transcriptase PCR. Results: The percentages of peripheral CXCR6þ PBLs did not differ between GD and normal subjects. CXCR6 was expressed by small subsets of circulating T-cells and natural killer (NK) cells. CXCR6þ cells were enriched in thyroid-derived T-cells compared with peripheral CD4þ and CD8þ T-cells in GD. The increase was evident within the Th1 (CD4þ interferon-gþ (IFN-gþ)) and Tc1 (CD8þIFN- gþ) subpopulation and CD8þ granzyme Aþ T-cells (cytotoxic effector type).
    [Show full text]
  • Effect of Prostanoids on Human Platelet Function: an Overview
    International Journal of Molecular Sciences Review Effect of Prostanoids on Human Platelet Function: An Overview Steffen Braune, Jan-Heiner Küpper and Friedrich Jung * Institute of Biotechnology, Molecular Cell Biology, Brandenburg University of Technology, 01968 Senftenberg, Germany; steff[email protected] (S.B.); [email protected] (J.-H.K.) * Correspondence: [email protected] Received: 23 October 2020; Accepted: 23 November 2020; Published: 27 November 2020 Abstract: Prostanoids are bioactive lipid mediators and take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. In this review, we focus on their influence on platelets, which are key elements in thrombosis and hemostasis. The function of platelets is influenced by mediators in the blood and the vascular wall. Activated platelets aggregate and release bioactive substances, thereby activating further neighbored platelets, which finally can lead to the formation of thrombi. Prostanoids regulate the function of blood platelets by both activating or inhibiting and so are involved in hemostasis. Each prostanoid has a unique activity profile and, thus, a specific profile of action. This article reviews the effects of the following prostanoids: prostaglandin-D2 (PGD2), prostaglandin-E1, -E2 and E3 (PGE1, PGE2, PGE3), prostaglandin F2α (PGF2α), prostacyclin (PGI2) and thromboxane-A2 (TXA2) on platelet activation and aggregation via their respective receptors. Keywords: prostacyclin; thromboxane; prostaglandin; platelets 1. Introduction Hemostasis is a complex process that requires the interplay of multiple physiological pathways. Cellular and molecular mechanisms interact to stop bleedings of injured blood vessels or to seal denuded sub-endothelium with localized clot formation (Figure1).
    [Show full text]
  • The Role of CXCR5 and Its Ligand CXCL13 in The
    European Journal of Endocrinology (2004) 150 225–234 ISSN 0804-4643 EXPERIMENTAL STUDY The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases G Aust, D Sittig, L Becherer1, U Anderegg2, A Schu¨tz3, P Lamesch1 and E Schmu¨cking Institute of Anatomy, 1Department of Surgery, 2Department of Dermatology and 3 Institute of Pathology, University of Leipzig, Leipzig, Germany (Correspondence should be addressed to G Aust, University of Leipzig, Institute of Anatomy, Ph-Rosenthal-Strasse 55, Leipzig, 04103, Germany; Email: [email protected]) Abstract Objective: Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are characterized by lymphocytic infiltrates partly resembling secondary lymphoid follicles in the thyroid. CXCR5 and its ligand CXCL13 regulate compartmentalization of B- and T-cells in secondary lymphoid organs. The aim of the study was to elucidate the role of this chemokine receptor–ligand pair in thyroid autoimmunity. Methods: Peripheral blood and thyroid-derived lymphocyte subpopulations were examined by flow cyto- metry for CXCR5. CXCR5 and CXCL13 cDNA were quantified in thyroid tissues by real-time RT-PCR. Results: We found no differences between the percentages of peripheral blood CXCR5þ T- and B-cells in GD patients (n ¼ 10) and healthy controls (n ¼ 10). In GD patients, the number of memory CD4þ cells expressing CXCR5 which are functionally characterized as follicular B helper T-cells is higher in thyroid- derived (18^3%) compared with peripheral blood T-lymphocytes (8^2%). The highest CXCL13 mRNA levels were found in HT (n ¼ 2, 86.1^1.2 zmol (10221 mol) cDNA/PCR) followed by GD tissues (n ¼ 16, 9.6^3.5).
    [Show full text]